Cargando…
Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
Autor principal: | Rabie, Amgad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166213/ https://www.ncbi.nlm.nih.gov/pubmed/35692492 http://dx.doi.org/10.1007/s11696-022-02315-9 |
Ejemplares similares
-
RETRACTED ARTICLE: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
por: Rabie, Amgad M.
Publicado: (2021) -
Cyanorona-20: The first potent anti-SARS-CoV-2 agent
por: Rabie, Amgad M.
Publicado: (2021) -
Retraction Note: CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy
por: Rabie, Amgad M.
Publicado: (2022) -
Retraction Note: Growth inhibition and apoptosis induced by 6-fluoro-3-formylchromone in hepatocellular carcinoma
por: Zhang, Yijie, et al.
Publicado: (2015) -
RETRACTION NOTE
Publicado: (2012)